Establishing Potential Endpoints in Clinical Trials to Innovate Treatment

Time: 1:00 pm
day: Pre-Conference Workshop Day


Considering the significant debate surrounding the optimal endpoint for demonstrating efficacy of next generation cardiovascular therapeutics, an active discussion is essential to move forward.


Attend this workshop to evaluate the current regulation on clinical endpoints to identify the windows of opportunity for the future of precise and targeted therapeutics within the cardiovascular industry.


Highlights include:

  • Evaluating clinically meaningful endpoints and alternatives to invasive procedures to stimulate patient engagement in trials
  • Assessing strategies for engaging regulatory authorities in discussions on redefining approvable endpoints
  • Identifying easily measured and highly correlated surrogate endpoints to shorten studies and reduce sample size